Evidence map›Paper›PMID 42553773›Full record

ReviewInternational journal of nanomedicine2026

Advances in the Rational Design, Mechanisms, and Applications of Lanthanide Nanoparticles for the Regulation of Reactive Oxygen Species.

Zheng Zhao, Yanan Liang, Hongtao Lan, Jiatong Wu, Tiantian Shan, Changan Qu, Sijia Liu, Xianming Chu

Abstract readReview
In one paragraph

Review in International journal of nanomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zheng ZhaoDepartment of Cardiology, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, 266000, People's Republic of China.
Yanan LiangDepartment of Oncology, Qingdao West Coast Second Hospital, Qingdao, 266500, People's Republic of China.
Hongtao LanDepartment of Cardiology, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, 266000, People's Republic of China.
Jiatong WuDepartment of Cardiology, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, 266000, People's Republic of China.
Tiantian ShanDepartment of Cardiology, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, 266000, People's Republic of China.
Changan QuDepartment of Cardiology, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, 266000, People's Republic of China.
Sijia LiuDepartment of Cardiology, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, 266000, People's Republic of China.
Xianming ChuDepartment of Cardiology, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, 266000, People's Republic of China.ORCID 0000-0003-4755-162X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lanthanide nanoparticles provide an ideal platform for the precise regulation of reactive oxygen species (ROS) due to their reversible redox properties, photomagnetic characteristics, and functionalizable surfaces. This review summarizes recent advances in the mechanistic understanding, biomedical applications, and material design strategies of lanthanide nanoparticles for ROS modulation. Mechanistically, lanthanide nanoparticles generate ROS through photoexcited electron transfer, Fenton-like reactions, and ligand-mediated redox cycling, while also effectively scavenging ROS via reversible valence switching and metal-ligand synergistic effects. At the application level, these nanoparticles leverage their combined antioxidant and anti-inflammatory properties to provide protection against oxidative stress-related diseases, while enabling targeted tumor elimination through chemodynamic therapy, photodynamic therapy, sonodynamic therapy, radiosensitization, and multimodal imaging. Recent material design has encompassed upconversion architectures, multi-metal composite systems, single-atom catalysts, biodegradable systems, and artificial intelligence-assisted rational design. Despite remaining challenges in understanding metabolic pathways and achieving targeting precision, the integration of lanthanide nanomaterials with emerging therapeutic modalities and intelligent design strategies holds promise for innovative approaches to the diagnosis and treatment of ROS-associated diseases.

Indexed as

Lanthanoid Series ElementsMetal NanoparticlesReactive Oxygen SpeciesAnimalsAntioxidantsHumansOxidative StressAntioxidantsLanthanoid Series ElementsReactive Oxygen Speciesdisease therapylanthanide elementsnanoparticlesrational designreactive oxygen speciesROS

Identifiers

PMID42553773
PMCPMC13436571

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.